PubMed چکیده/رکورد

Ocular topical aesculetin delivery via VA64/TPGS co-assembled micelles for redox-inflammatory modulation in selenite-induced cataract.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Cataract progression is closely associated with oxidative stress and inflammatory activation, while effective non-surgical interventions remain limited. Aesculetin (AES) possesses antioxidant and anti-inflammatory activities, but its topical ophthalmic application is restricted by poor aqueous solubility, insufficient dispersion stability, and limited local availability. Here, AES-loaded VA64/TPGS co-assembled micelles (AES@V-T) were developed as a topical ophthalmic delivery system. The optimized AES@V-T showed a mean particle size of 13.10 ± 0.16 nm, a narrow polydispersity index of 0.094 ± 0.020, and an encapsulation efficiency above 99%, indicating the formation of a uniform nanoscale colloidal system with efficient drug incorporation. Compared with free AES, AES@V-T increased the apparent solubility of AES in artificial tears by 501-fold and enhanced its 12 h cumulative release from 9.32% to 59.84%. Cou-6 incorporated into the AES@V-T formulation produced stronger corneal-associated fluorescence than the free probe, providing qualitative evidence of improved corneal presentation of a model hydrophobic payload. In an ex vivo post-exposure lens injury model, AES@V-T preserved lens transparency and attenuated abnormal swelling. Topical administration of AES@V-T also markedly attenuated cataract development in sodium selenite-treated rat pups. Biochemical analyses showed that AES@V-T reduced lipid peroxidation and oxidative DNA damage, improved endogenous antioxidant defenses, and decreased the lens levels of HMGB1, total NF-κB p65, and pro-inflammatory cytokines, consistent with attenuation of the inflammatory-marker profile associated with sodium selenite-induced injury. These findings indicate that VA64/TPGS co-assembly improved the aqueous formulation state and topical ocular performance of AES, supporting its enhanced protection against sodium selenite-induced lens injury.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

AesculetinCataractCo-assemblyMicellesOcular delivery
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

Decoding Nano-Bio Interactions: Gene Regulatory Networks in Advanced Drug Loading.

Conventional treatments often face challenges such as the limited ability to penetrate the blood-brain barrier (BBB). The Doxorubicin-loaded graphene oxide/magnetite (DOX/GO/Fe3O4) nanocomplex offers a promising platform due to GO's high surface area and pH-sensitive release, and Fe3O4's magnetic properties. This protocol describes the methodology for evaluating the cytotoxicity of free DOX versus the DOX/GO/Fe3O4 nanocomplex in the A-…

PubMed2026

Formulation, evaluation and characterization of fexofenadine IR and paracetamol SR multiparticulate drug delivery system.

BACKGROUND: Multiparticulate Drug Delivery (MDD) system are particularly considered as well suited systems for controlling oral preparations that have low risk of dose-dumping. OBJECTIVES: The current research work was aimed to prepare Fexofenadine HCl immediate release (IR) and Paracetamol sustained release (SR) pellets in a single dosage unit for the treatment of Allergic Rhinitis. Extrusion-spheronization was used to fabricate pelle…

PubMed2026

Improved transcutaneous delivery of cetirizine hydrochloride for the treatment of post-chemotherapy alopecia: Poke and emulgel approach.

BACKGROUND: Chemotherapy-induced alopecia negatively impacts the mental health of cancer patients. Topical minoxidil, a widely recommended drug for hair regrowth, causes scalp irritation and contact dermatitis. Oral minoxidil causes multiple cardiovascular and neurological side effects. Cetirizine hydrochloride, an antihistamine with a better safety profile than minoxidil, may stimulate hair follicle activity by modulating prostaglandi…